Trials / Conditions / High-grade B-cell Lymphoma (HGBL)
High-grade B-cell Lymphoma (HGBL)
3 registered clinical trials studyying High-grade B-cell Lymphoma (HGBL) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) NCT07197307 | Universität Münster | Phase 2 |
| Recruiting | Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients NCT07473167 | TICAROS Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymp NCT01742988 | Curis, Inc. | Phase 1 |